Announcements Trials
Browse Landscape

Status

Completed 26Unknown 10Terminated 8Recruiting 8Withdrawn 7Active not recruiting 4No longer available 3

Sponsor Class

OTHER 3

Study Type

Expanded_access 3

Sponsor

Cancer Type

Endocrine 3NET 1Head & Neck 1CNS 1

Conditions

Prostatic Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neuroblastoma 5Multiple Myeloma 5Lambert-Eaton Myasthenic Syndrome 5Leukemia 4Carcinoma, Hepatocellular 4Precancerous Conditions 3Pheochromocytoma 3Neuroendocrine Tumors 3Myelodysplastic Syndromes 3Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Glioblastoma 3Carcinoid Tumor 3Sarcoma, Ewing 2Sarcoma 2Paraganglioma 2Neoplasms 2Neoplasm Metastasis 2Melanoma 2Liver Neoplasms 2Immunoproliferative Disorders 2Immune System Diseases 2Hodgkin Disease 2Graft vs Host Disease 2Glioma 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1

Interventions

gallium Ga 68 dotatate 1fluorodopa F 18 1Gallium-68 1Ga(III)-DOTATOC 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
No longer available × OTHER × Carcinoid Tumor × Clear all
NCT02431715 2023-02-21

18F-FDOPA PET in Neuroendocrine Tumours

British Columbia Cancer Agency

No longer available
CNSEndocrineHead & Neck

Thyroid cancer, medullary, Carcinoid Tumor, Insulinoma, Neuroblastoma, Paraganglioma, Pheochromocytoma

NCT01980732 2017-08-23

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Stanford University

No longer available
Endocrine

Carcinoid Tumor, Adenoma, Islet Cell

NCT02375464 2016-11-08

Gallium-68 DOTATOC for Management of Neuroendocrine Tumors

Northwell Health

No longer available
EndocrineNET

Carcinoid Tumor, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡